Truist Financial Cuts Humana (NYSE:HUM) Price Target to $305.00

Humana (NYSE:HUM - Get Free Report) had its target price dropped by stock analysts at Truist Financial from $325.00 to $305.00 in a note issued to investors on Monday,Benzinga reports. The firm presently has a "hold" rating on the insurance provider's stock. Truist Financial's target price points to a potential upside of 38.86% from the stock's previous close.

Other research analysts have also recently issued research reports about the stock. Morgan Stanley decreased their price objective on shares of Humana from $301.00 to $285.00 and set an "equal weight" rating for the company in a report on Wednesday, February 12th. Robert W. Baird upped their price target on shares of Humana from $270.00 to $300.00 and gave the company a "neutral" rating in a report on Tuesday, April 15th. Piper Sandler increased their price objective on shares of Humana from $270.00 to $288.00 and gave the stock a "neutral" rating in a research report on Wednesday, January 15th. JPMorgan Chase & Co. reduced their target price on shares of Humana from $257.00 to $256.00 and set a "neutral" rating for the company in a research note on Tuesday, February 18th. Finally, Oppenheimer lifted their price target on Humana from $300.00 to $310.00 and gave the company an "outperform" rating in a research note on Thursday, May 1st. Seventeen research analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of "Hold" and a consensus price target of $286.81.

Humana Price Performance

HUM stock traded down $10.83 during trading on Monday, hitting $219.64. 1,679,992 shares of the stock traded hands, compared to its average volume of 1,754,722. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.68. The stock has a market cap of $26.51 billion, a price-to-earnings ratio of 22.08, a P/E/G ratio of 2.05 and a beta of 0.49. Humana has a one year low of $212.58 and a one year high of $406.46. The company has a 50 day simple moving average of $263.70 and a 200 day simple moving average of $269.85.

Humana (NYSE:HUM - Get Free Report) last announced its earnings results on Wednesday, April 30th. The insurance provider reported $11.58 earnings per share for the quarter, beating analysts' consensus estimates of $10.07 by $1.51. Humana had a return on equity of 11.70% and a net margin of 1.02%. The company had revenue of $32.11 billion during the quarter, compared to analyst estimates of $32 billion. During the same period last year, the company posted $7.23 earnings per share. The firm's quarterly revenue was up 8.4% compared to the same quarter last year. Equities analysts expect that Humana will post 16.47 EPS for the current fiscal year.

Hedge Funds Weigh In On Humana

Hedge funds have recently added to or reduced their stakes in the stock. Pinnacle Wealth Management Advisory Group LLC increased its holdings in Humana by 3.6% in the 4th quarter. Pinnacle Wealth Management Advisory Group LLC now owns 1,070 shares of the insurance provider's stock valued at $272,000 after buying an additional 37 shares during the period. Mather Group LLC. increased its stake in Humana by 21.0% in the fourth quarter. Mather Group LLC. now owns 236 shares of the insurance provider's stock valued at $60,000 after acquiring an additional 41 shares during the last quarter. Capital Advisors Ltd. LLC raised its position in Humana by 26.1% during the fourth quarter. Capital Advisors Ltd. LLC now owns 208 shares of the insurance provider's stock valued at $53,000 after purchasing an additional 43 shares in the last quarter. Retirement Planning Co of New England Inc. lifted its stake in Humana by 4.7% during the fourth quarter. Retirement Planning Co of New England Inc. now owns 966 shares of the insurance provider's stock worth $245,000 after purchasing an additional 43 shares during the last quarter. Finally, LFA Lugano Financial Advisors SA boosted its holdings in shares of Humana by 56.3% in the 4th quarter. LFA Lugano Financial Advisors SA now owns 125 shares of the insurance provider's stock valued at $32,000 after purchasing an additional 45 shares in the last quarter. Institutional investors own 92.38% of the company's stock.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.